Healthcare & Life Sciences

Metaimmune Therapeutics

Germany
Sign in to unlock

About

Metaimmune Therapeutics is developing therapies intended as a lower–side-effect alternative to cortisone (corticosteroids), focusing on novel anti‑inflammatory/immunomodulatory drug development.

Explore Metaimmune Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing